Lux Biosciences is a biotechnology company developing medicines for the treatment of ophthalmic diseases.
Business Model:
Revenue: $0
Employees: 11-50
Address: -
City: New Jersey
State: NJ
Zip: 07303
Country: US
Lux Biosciences, Inc., a biotechnology company, develops medications to treat ophthalmic diseases. Its products include LX201, a silicone matrix ocular implant that enables the release of cyclosporine A to the eye for one year; Luveniq, an oral form of calcineurin inhibitor voclosporin; LX212, a bioerodible polymer implant that contains voclosporin; and LX214, a topical mixed nanomicellar formulation of voclosporin therapy for dry eyes. The company was founded in 2005 and is based in Jersey City, New Jersey.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2009 | Debt Financing | $9.2M | 7/2011 | Debt Financing | $6M | 12/2011 | Debt Financing | $4M | 3/2012 | Debt Financing | $16M | 12/2010 | Debt Financing | $5M | 1/2007 | Series A | 2 | $30.5M |
HBM Healthcare Investments AG Novo Holdings HBM Healthcare Investments AG Novo Holdings |
6/2006 | Series A | 2 | $8.4M |
HBM Healthcare Investments AG Novo Holdings HBM Healthcare Investments AG Novo Holdings |
10/2009 | Series B | 4 | $50M |
HBM Healthcare Investments AG Novo Holdings Prospect Venture Partners SV Health Investors HBM Healthcare Investments AG Novo Holdings Prospect Venture Partners SV Health Investors |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|